Chris Freeman - 15 Jun 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Issuer symbol
GH
Transactions as of
15 Jun 2025
Transactions value $
-$131,851
Form type
4
Filing time
16 Jun 2025, 20:03:04 UTC
Previous filing
02 Apr 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Freeman Chris Chief Commercial Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Chris Freeman 16 Jun 2025 0001871615

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +4.88K +11.31% $0.00 48K 15 Jun 2025 Direct
transaction GH Common Stock Options Exercise $0 +1.4K +2.92% $0.00 49.4K 15 Jun 2025 Direct
transaction GH Common Stock Tax liability -$132K -2.68K -5.41% $49.29 46.8K 15 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -4.88K -100% $0.00 0 15 Jun 2025 Common Stock 4.88K $0.00 Direct F2, F3
transaction GH Restricted Stock Units Options Exercise $0 -1.4K -20% $0.00 5.61K 15 Jun 2025 Common Stock 1.4K $0.00 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vested 25% of the shares subject to such award on June 15, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each anniversary of June 15, 2022 during the three-year period thereafter.
F3 Not applicable to Restricted Stock Units
F4 This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F5 Not applicable for Restricted Stock Units.

Remarks:

Table I includes 859 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2025.